DOCSLIB.ORG

2017 Proceedings Book

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

2017 30TH PROCEEDINGS OF NAVDF April 26-29, 2017 ORLANDO, FLORIDA 2 (orfenicol, terbinane, mometasone furoate) Otic Solution Antibacterial, antifungal, and anti-inammatory For Otic Use in Dogs Only The following information is a summary of the complete product information and is not comprehensive. Please refer to the approved product label for complete product information prior to use. CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. PRODUCT DESCRIPTION: CLARO® contains 16.6 mg/mL orfenicol, 14.8 mg/mL terbinane (equivalent to 16.6 mg/mL terbinane hydrochloride) and 2.2 mg/mL mometasone furoate. Inactive ingredients include puried water, propylene carbonate, propylene glycol, ethyl alcohol, and polyethylene glycol. INDICATIONS: CLARO® is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius). DOSAGE AND ADMINISTRATION: CLARO® should be administered by veterinary personnel. Administration is one dose (1 dropperette) per aected ear. The duration of eect should last 30 days. Clean and dry the external ear canal before administering the product. Verify the tympanic membrane is intact prior to administration. Cleaning the ear after dosing may aect product eectiveness. Refer to product label for complete directions for use. CONTRAINDICATIONS: Do not use in dogs with known tympanic membrane perforation (see PRECAUTIONS). CLARO® is contraindicated in dogs with known or suspected hypersensitivity to orfenicol, terbinane hydrochloride, or mometasone furoate, the inactive ingredients listed above, or similar drugs, or any ingredient in these medicines. WARNINGS: Human Warnings: Not for use in humans. Keep this and all drugs out of reach of children. In case of accidental ingestion by humans, contact a physician immediately. In case of accidental skin contact, wash area thoroughly with water. Avoid contact with eyes. Humans with known hypersensitivity to orfenicol, terbinane hydrochloride, or mometasone furoate should not handle this product. PRECAUTIONS: Do not administer orally. The use of CLARO® in dogs with perforated tympanic membranes has not been evaluated. The integrity of the tympanic membrane should be conrmed before administering the product. Reevaluate the dog if hearing loss or signs of vestibular dysfunction are observed during treatment. Use of topical otic corticosteroids has been associated with adrenocortical suppression and iatrogenic hyperadrenocorticism in dogs. Use with caution in dogs with impaired hepatic function. The safe use of CLARO® in dogs used for breeding purposes, during pregnancy, or in lactating bitches has not been evaluated. ADVERSE REACTIONS: In a eld study conducted in the United States, there were no directly attributable adverse reactions in 146 dogs administered CLARO®. To report suspected adverse drug events and/or obtain a copy of the Safety Data Sheet (SDS) or for technical assistance, contact Bayer HealthCare at 1-800-422-9874. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at http://www.fda.gov/AnimalVeterinary/SafetyHealth. NADA 141-440, Approved by FDA. Bayer, the Bayer Cross and CLARO are registered trademarks of Bayer. ©2016 Bayer HealthCare, LLC. Distributed by: Bayer HealthCare LLC, Animal Health Division, Shawnee Mission, Kansas 66201 • World-renowned Speakers • Exceptional Round Table Topics and Discussions • Informative Poster Displays • Industry Exhibitors • Lively Receptions • Two half days to allow for free time • And much, much, more in store For more information about North American Veterinary Dermatology Forum 2018, consult our website at navdf.org or call 1-866-854-5525 #NAVDF2018 NAVDF 2019 April 10-13 HILTON AUSTIN TABLE OF CONTENTS GENERAL INFORMATION ABSTRACTS Dex Game 7 THURSDAY 22 App 7 Residents’ Short Communications 22 Shuttle Schedule 8 Clinical Short Communications 23 A la Carte Lunch 8 Scientific Session Presentations 23 Hotel Map 9 Concurrent Session Presentations 23 Registration Hour 10 FRIDAY 91 Exhibit Hall Hours 10 Original Short Communications 91 Poster Hours 10 Clinical Short Communications 91 Exhibit Hall Map 10 Original and Clinical Short Communications 92 COMPLETE SCHEDULE Scientific Session Presentations 92 Wednesday 13 Concurrent Session Presentations 92 Thursday 14 SATURDAY 142 Friday 16 Scientific Session Presentations 142 Saturday 18 Concurrent Session Presentations 142 ISVD Sessions 143 ROUNDTABLE SESSIONS ADVT Sessions 143 Thursday 20 POSTERS 206 Friday 20 Saturday 20 6 LOSTLOST DOG DOG Dex disappeared from his dog house! Please keep an eye out for him around the conference. If you spot him make sure to snap a photo and share it on the app using your Instagram account. Remember to tag the NAVDF (@NAVDF) and use the hashtag #detectDex. Once your photo is shared, return Dex to his dog house at NAVDF registration and claim your reward! App Download Instructions 1. Search NAVDF in App Store 2. Click "GET" to download 1. Search NAVDF in Google Play 2. Click “Install” to download LAPTOP OR Use https://crowd.cc/2017navdf OTHER DEVICES for online version of the app 7 SHUTTLE SCHEDULE Shuttle from Animal Kingdom Lodge to Contemporary: Wednesday: 3:30 pm – 8:30 pm Thursday: 6:30 am – 6:30 pm Friday: 6:30 am – 4:30 pm Saturday: 6:30 am – 6:30 pm The shuttle will run bottom of each hour (:30) pick up/ drop off at Animal Kingdom odgeL and top of each hour (:00) pick up/ drop off at the Contemporary. Local Taxi Companies: Diamond Cab Company : 407-523-3333 Taxi Orlando Cab Service: 321-732-8266 Visit Disney's Yellow Cab Orlando: 407-900-5207 Magical Express for complimentary App Cars: transportation to and Uber from the airport. Lyft A LA CARTE LUNCH A la Carte Lunch 12:30 – 2:30 pm Visit Disney Dining for all the options on Disney Properties: https://disneyworld.disney.go.com/dining/ Ala Carte Lunches will be available at the Contemporary in the Convention Porte Cochere area during the lunch break time period. All seating is outside under the Porte Cochere. 8 HOTELDISNEY’S CONTEMPORARY MEETING RESORT –SPACE MAIN LEVEL Sorcerer’s Apprentice Lobby Sorcerer’s Sorcerer’s Apprentice Ballroom Apprentice Courtyard ©Disney 9 REGISTRATION & EXHIBIT HALL HOURS REGISTRATION HOURS Wednesday, April 26 5:00pm - 7:00pm Thursday, April 27 7:00am - 5:30pm Friday, April 28 7:30am - 5:30pm Saturday, April 29 7:30am - 5:30pm EXHIBIT HALL & POSTER HOURS Thursday, April 27 8:30am - 4:30pm Friday, April 28 8:30am - 3:30pm Saturday, April 29 8:30am - 11:30am 10 11 Baytril® Otic (enrofloxacin/silver sulfadiazine) Antibacterial-Antimycotic Emulsion For Ototopical Use In Dogs Caution: Federal (U.S.A.) Law restricts this drug to use by or on the order of a licensed veterinarian. Federal law prohibits the extralabel use of this drug in food-producing animals. PRODUCT DESCRIPTION: Each milliliter of Baytril® Otic contains: enrofloxacin 5 mg (0.5% w/v), silver sulfadiazine (SSD) 10 mg (1.0% w/v), benzyl alcohol (as a preservative) and cetylstearyl alcohol (as a stabilizer) in a neutral oil and purified water emulsion. The active ingredients are delivered via a physiological carrier (a nonirritating emulsion). MICROBIOLOGY: In clinical field trials, Baytril® Otic demonstrated elimination or reduction of clinical signs associated with otitis externa and in vitro activity against cultured organisms. Baytril® Otic is effective when used as a treatment for canine otitis externa associated with one or more of the following organisms: Malassezia pachydermatis, coagulase-positive Staphylococcus spp., Pseudomonas aeruginosa, Enterobacter spp., Proteus mirabilis, Streptococci spp., Aeromonas hydrophila, Aspergillus spp., Klebsiella pneumoniae, and Candida albicans. INDICATIONS: Baytril® Otic is indicated as a treatment for canine otitis externa complicated by bacterial and fungal organisms susceptible to enrofloxacin and/or silver sulfadiazine (see Microbiology section). EFFECTIVENESS: Due to its combination of active ingredients, Baytril® Otic provides antimicrobial therapy against bacteria and fungi (which includes yeast) commonly encountered in cases of canine otitis externa. CONTRAINDICATIONS: Baytril® Otic is contraindicated in dogs with suspected or known hypersensitivity to quinolones and/or sulfonamides. HUMAN WARNINGS: Not for human use. Keep out of the reach of children. Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult a physician if irritation develops or persists following ocular or dermal exposures. Individuals with a history of hypersensitivity to quinolone compounds or antibacterials should avoid handling this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight. PRECAUTIONS: The use of Baytril® Otic in dogs with perforated tympanic membranes has not been evaluated. Therefore, the integrity of the tympanic membrane should be evaluated before administering this product. If hearing or vestibular dysfunction is noted during the course of treatment, discontinue use of Baytril® Otic. Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with
Recommended publications
  • In This Issue

    In This Issue

    the Practical Farmer A quarterly publication of Practical Farmers of Iowa Vol. 27, No. 1 | Winter 2012 Wyatt Wheeler hides in the hay at a pasture walk held at Jake and Amber Wheeler’s farm near Monroe this winter. In this issue How specialty crops can supplement farm income Savings Incentive Program: 25 new farmers embark on 2-year quest Field crops: Profit more by using less, without sacrificing yield Special 2012 PFI Annual Conference photo section Solar PV pays off for PFI members PFI Board of Directors We love to hear from you! Please feel free to contact your board members or PFI staff . Contents DISTRICT 1 (NORTHWEST) Gail Hickenbottom, Treasurer David Haden 810 Browns Woods Dr . Letter from the Director . 3 4458 Starling Ave . West Des Moines, IA 50265 Primghar, IA 51245 515 .256 .7876 712 .448 .2012 Horticulture . 4–5 highland33@tcaexpress .net ADVISORY BOARD Dan Wilson, PFI Vice-President Larry Kallem 2011 Beginning Farmer Retreat . .6–7 4375 Pierce Ave . 12303 NW 158th Ave . Paullina, IA 51046 Madrid, IA 50156 712 .448 .3870 515 .795 .2303 PFI Leaders . 8–9 the7wilsons@gmail .com Dick Thompson 2035 190th St . DISTRICT 2 (NORTH CENTRAL) Boone, IA 50036 Savings Incentive Program . .10–11 Sara Hanson 515 .432 .1560 2505 220th Ave . Field Crops . .12–13 Wesley, IA 50483 PFI STAFF 515 .928 .7690 dancingcarrot@yahoo .com For general information and staff Climate Change . 14–15. connections, call 515.232.5661. Tim Landgraf, PFI President Individual extensions are listed in 1465 120th St . 2012 PFI Annual Conference . 16-19 Kanawha, IA 50447 parentheses after each name.
  • Successful Management of 3 Dogs with Colonic Pythiosis Using Itraconzaole, Terbinafine, and Prednisone

    Successful Management of 3 Dogs with Colonic Pythiosis Using Itraconzaole, Terbinafine, and Prednisone

    UC Davis UC Davis Previously Published Works Title Successful management of 3 dogs with colonic pythiosis using itraconzaole, terbinafine, and prednisone. Permalink https://escholarship.org/uc/item/2119g65v Journal Journal of veterinary internal medicine, 33(3) ISSN 0891-6640 Authors Reagan, Krystle L Marks, Stanley L Pesavento, Patricia A et al. Publication Date 2019-05-01 DOI 10.1111/jvim.15506 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Received: 19 January 2019 Accepted: 8 April 2019 DOI: 10.1111/jvim.15506 CASE REPORT Successful management of 3 dogs with colonic pythiosis using itraconzaole, terbinafine, and prednisone Krystle L. Reagan1 | Stanley L. Marks2 | Patricia A. Pesavento3 | Ann Della Maggiore1 | Bing Y. Zhu1 | Amy M. Grooters4 1Veterinary Medical Teaching Hospital, University of California Davis, Davis, California Abstract 2Department of Medicine and Epidemiology, Gastrointestinal (GI) pythiosis is a severe and often fatal disease in dogs that School of Veterinary Medicine, University of traditionally has been poorly responsive to medical treatment. Although aggressive sur- California, Davis, California 3Department of Pathology, Microbiology, and gical resection with wide margins is the most consistently effective treatment, lesion Immunology, School of Veterinary Medicine, location and extent often preclude complete resection. Recently, it has been suggested University of California, Davis, California that the addition of anti-inflammatory doses of corticosteroids may improve outcome 4Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State in dogs with nonresectable GI pythiosis. This report describes 3 dogs with colonic University, Baton Rouge, Louisiana pythiosis in which complete resolution of clinical signs, regression of colonic masses, Correspondence and progressive decreases in serological titers were observed after treatment with Krystle L.
  • Microbiology Laboratory Exercises Third Edition 2020

    Microbiology Laboratory Exercises Third Edition 2020

    MICROBIOLOGY Laboratory Exercises Third Edition Keddis & Rauschenbach 2020 Photo Credits (in order of contribution): Diane Davis, Ines Rauschenbach & Ramaydalis Keddis Acknowledgements: Many thanks to those in the Department of Biochemistry and Microbiology, Rutgers University, who have through the years inspired our enthusiasm for the science and teaching of microbiology, with special thanks to Diane Davis, Douglas Eveleigh and Max Häggblom. Safety: The experiments included in this manual have been deemed safe by the authors when all necessary safety precautions are met. The authors recommend maintaining biosafety level 2 in the laboratory setting and using risk level 1 organisms for all exercises. License: This work is licensed under a Creative Commons Attribution- NonCommercial-NoDerivatives 4.0 International License Microbiology Laboratory Exercises Third Edition 2020 Ramaydalis Keddis, Ph.D. Ines Rauschenbach, Ph.D. Department of Biochemistry and Microbiology Rutgers, The State University of New Jersey CONTENTS PAGE Introduction Schedule ii Best Laboratory Practices Iii Working in a Microbiology Laboratory iv Exercises Preparation of a Culture Medium 1 Culturing and Handling Microorganisms 3 Isolation of a Pure Culture 5 Counting Bacterial Populations 8 Controlling Microorganisms 10 Disinfectants 10 Antimicrobial Agents: Susceptibility Testing 12 Hand Washing 14 The Lethal Effects of Ultraviolet Light 15 Selection of Fungi from Air 17 Microscopy 21 Morphology and Staining of Bacteria 26 Microbial Metabolism 30 Enzyme Assay 32 Metabolic
  • 18 December 2020 – to Date)

    18 December 2020 – to Date)

    (18 December 2020 – to date) MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 (Gazette No. 1171, Notice No. 1002 dated 7 July 1965. Commencement date: 1 April 1966 [Proc. No. 94, Gazette No. 1413] SCHEDULES Government Notice 935 in Government Gazette 31387 dated 5 September 2008. Commencement date: 5 September 2008. As amended by: Government Notice R1230 in Government Gazette 32838 dated 31 December 2009. Commencement date: 31 December 2009. Government Notice R227 in Government Gazette 35149 dated 15 March 2012. Commencement date: 15 March 2012. Government Notice R674 in Government Gazette 36827 dated 13 September 2013. Commencement date: 13 September 2013. Government Notice R690 in Government Gazette 36850 dated 20 September 2013. Commencement date: 20 September 2013. Government Notice R104 in Government Gazette 37318 dated 11 February 2014. Commencement date: 11 February 2014. Government Notice R352 in Government Gazette 37622 dated 8 May 2014. Commencement date: 8 May 2014. Government Notice R234 in Government Gazette 38586 dated 20 March 2015. Commencement date: 20 March 2015. Government Notice 254 in Government Gazette 39815 dated 15 March 2016. Commencement date: 15 March 2016. Government Notice 620 in Government Gazette 40041 dated 3 June 2016. Commencement date: 3 June 2016. Prepared by: Page 2 of 199 Government Notice 748 in Government Gazette 41009 dated 28 July 2017. Commencement date: 28 July 2017. Government Notice 1261 in Government Gazette 41256 dated 17 November 2017. Commencement date: 17 November 2017. Government Notice R1098 in Government Gazette 41971 dated 12 October 2018. Commencement date: 12 October 2018. Government Notice R1262 in Government Gazette 42052 dated 23 November 2018.
  • Abyssinian Cat Club Type: Breed

    Abyssinian Cat Club Type: Breed

    Abyssinian Cat Association Abyssinian Cat Club Asian Cat Association Type: Breed - Abyssinian Type: Breed – Abyssinian Type: Breed – Asian LH, Asian SH www.abycatassociation.co.uk www.abyssiniancatclub.com http://acacats.co.uk/ Asian Group Cat Society Australian Mist Cat Association Australian Mist Cat Society Type: Breed – Asian LH, Type: Breed – Australian Mist Type: Breed – Australian Mist Asian SH www.australianmistcatassociation.co.uk www.australianmistcats.co.uk www.asiangroupcatsociety.co.uk Aztec & Ocicat Society Balinese & Siamese Cat Club Balinese Cat Society Type: Breed – Aztec, Ocicat Type: Breed – Balinese, Siamese Type: Breed – Balinese www.ocicat-classics.club www.balinesecatsociety.co.uk Bedford & District Cat Club Bengal Cat Association Bengal Cat Club Type: Area Type: PROVISIONAL Breed – Type: Breed – Bengal Bengal www.thebengalcatclub.com www.bedfordanddistrictcatclub.com www.bengalcatassociation.co.uk Birman Cat Club Black & White Cat Club Blue Persian Cat Society Type: Breed – Birman Type: Breed – British SH, Manx, Persian Type: Breed – Persian www.birmancatclub.co.uk www.theblackandwhitecatclub.org www.bluepersiancatsociety.co.uk Blue Pointed Siamese Cat Club Bombay & Asian Cats Breed Club Bristol & District Cat Club Type: Breed – Siamese Type: Breed – Asian LH, Type: Area www.bpscc.org.uk Asian SH www.bristol-catclub.co.uk www.bombayandasiancatsbreedclub.org British Shorthair Cat Club Bucks, Oxon & Berks Cat Burmese Cat Association Type: Breed – British SH, Society Type: Breed – Burmese Manx Type: Area www.burmesecatassociation.org
  • "First Report on the State of the World's Animal Genetic Resources"

    "First Report on the State of the World's Animal Genetic Resources"

    Country Report of Australia for the FAO First Report on the State of the World’s Animal Genetic Resources 2 EXECUTIVE SUMMARY................................................................................................................5 CHAPTER 1 ASSESSING THE STATE OF AGRICULTURAL BIODIVERSITY THE FARM ANIMAL SECTOR IN AUSTRALIA.................................................................................7 1.1 OVERVIEW OF AUSTRALIAN AGRICULTURE, ANIMAL PRODUCTION SYSTEMS AND RELATED ANIMAL BIOLOGICAL DIVERSITY. ......................................................................................................7 Australian Agriculture - general context .....................................................................................7 Australia's agricultural sector: production systems, diversity and outputs.................................8 Australian livestock production ...................................................................................................9 1.2 ASSESSING THE STATE OF CONSERVATION OF FARM ANIMAL BIOLOGICAL DIVERSITY..............10 Major agricultural species in Australia.....................................................................................10 Conservation status of important agricultural species in Australia..........................................11 Characterisation and information systems ................................................................................12 1.3 ASSESSING THE STATE OF UTILISATION OF FARM ANIMAL GENETIC RESOURCES IN AUSTRALIA. ........................................................................................................................................................12
  • Lindane Lotion USP, 1% RX Only WARNINGS

    Lindane Lotion USP, 1% RX Only WARNINGS

    Lindane Lotion USP, 1% RX Only WARNINGS: Lindane Lotion should only be used in patients who cannot tolerate or have failed first-line treatment with safer medications for the treatment of scabies. (See INDICATIONS AND USAGE.) Neurologic Toxicity Seizures and deaths have been reported following Lindane Lotion use with repeat or prolonged application, but also in rare cases following a single application used according to directions. Lindane lotion should be used with caution for infants, children, the elderly, and individuals with other skin conditions (e.g, atopic dermatitis, psoriasis) and in those who weigh < 110 lbs (50 kg) as they may be at risk of serious neurotoxicity. Contraindications Lindane Lotion is contraindicated in premature infants and individuals with known uncontrolled seizure disorders. Proper Use Instruct patients on the proper use of Lindane Lotion, the amount to apply, how long to leave it on, and avoiding re-treatment. Inform patients that itching occurs after the successful killing of scabies and is not necessarily an indication for re-treatment with Lindane Lotion. (See DOSAGE AND ADMINISTRATION.) DESCRIPTION Lindane Lotion USP, 1%, is an ectoparasiticide and ovicide. In addition to the active ingredient, lindane, it contains glycerol monostearate, cetyl alcohol, stearic acid, trolamine, carrageenan, 2- amino-2-methyl-1-propanol, methylparaben, butylparaben, perfume and water to form a lotion. Lindane is the gamma isomer of 1,2,3,4,5,6-hexachlorocyclohexane having the following structural formula: C6H6Cl6 M.W. 290.83 CLINICAL PHARMACOLOGY Lindane Lotion USP, 1%, is an ectoparasiticide and ovicide effective against Sarcoptes scabiei (scabies). Lindane exerts its parasiticidal action by being directly absorbed into the parasites and 1 their ova.
  • Revised Use-Function Classification (2007)

    Revised Use-Function Classification (2007)

    INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY IPCS INTOX Data Management System (INTOX DMS) Revised Use-Function Classification (2007) The Use-Function Classification is used in two places in the INTOX Data Management System: the Communication Record and the Agent/Product Record. The two records are linked: if there is an agent record for a Centre Agent that is the subject of a call, the appropriate Intended Use-Function can be selected automatically in the Communication Record. The Use-Function Classification is used when generating reports, both standard and customized, and for searching the case and agent databases. In particular, INTOX standard reports use the top level headings of the Intended Use-Functions that were selected for Centre Agents in the Communication Record (e.g. if an agent was classified as an Analgesic for Human Use in the Communication Record, it would be logged as a Pharmaceutical for Human Use in the report). The Use-Function classification is very important for ensuring harmonized data collection. In version 4.4 of the software, 5 new additions were made to the top levels of the classification provided with the system for the classification of organisms (items XIV to XVIII). This is a 'convenience' classification to facilitate searching of the Communications database. A taxonomic classification for organisms is provided within the INTOX DMS Agent Explorer. In May/June 2006 INTOX users were surveyed to find out whether they had made any changes to the Use-Function Classification. These changes were then discussed at the 4th and 5th Meetings of INTOX Users. Version 4.5 of the INTOX DMS includes the revised pesticides classification (shown in full below).
  • Malassezia Species Associated with Dermatitis in Dogs and Their Antifungal Susceptibility

    Malassezia Species Associated with Dermatitis in Dogs and Their Antifungal Susceptibility

    Int.J.Curr.Microbiol.App.Sci (2018) 7(6): 1994-2007 International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 06 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.706.236 Malassezia Species Associated With Dermatitis in Dogs and Their Antifungal Susceptibility Uday Seetha, Sumanth Kumar, Raghavan Madhusoodanan Pillai, Mouttou Vivek Srinivas*, Prabhakar Xavier Antony and Hirak Kumar Mukhopadhyay Department of Veterinary Microbiology, Rajiv Gandhi Institute of Veterinary Education and Research, Pondicherry-605 009, India *Corresponding author ABSTRACT The present study was taken with the objective of isolation, characterization, molecular detection and antifungal sensitivity of Malassezia species from dermatitis cases from dogs in and around Pondicherry state. A total of 100 skin swabs were collected from the dogs K e yw or ds showing dermatological problems suggestive of Malassezia. Out of 100 swabs, 41 Malassezia isolates were successfully isolated and had good growth on Sabouraud’s Malassezia pachydermatis, Dextrose Agar (SDA) during the primary isolation from the skin swabs. Biochemical tests Sabouraud’s dextrose agar, Modified Dixon’s agar, for catalase, β- glucosidase activities and the capability to grow with three water soluble Polymerase chain reaction, lipid supplements, namely Tween 20, Tween 80 and Cremophor EL concluded that the M. Antifungal Susceptibility testing pachydermatis was the sole species isolated from the cases of canine dermatitis in Pondicherry state. Cytological examination revealed that direct skin swab smear was more Article Info sensitive than adhesive tape technique and impression smear. The frequency of isolation of Accepted: M. pachydermatis was higher in neck region (8) followed by other regions in canine.
  • Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011

    Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011

    CLASSIFICATION DECISIONS TAKEN BY THE HARMONIZED SYSTEM COMMITTEE FROM THE 47TH TO 60TH SESSIONS (2011 - 2018) WORLD CUSTOMS ORGANIZATION Rue du Marché 30 B-1210 Brussels Belgium November 2011 Copyright © 2011 World Customs Organization. All rights reserved. Requests and inquiries concerning translation, reproduction and adaptation rights should be addressed to [email protected]. D/2011/0448/25 The following list contains the classification decisions (other than those subject to a reservation) taken by the Harmonized System Committee ( 47th Session – March 2011) on specific products, together with their related Harmonized System code numbers and, in certain cases, the classification rationale. Advice Parties seeking to import or export merchandise covered by a decision are advised to verify the implementation of the decision by the importing or exporting country, as the case may be. HS codes Classification No Product description Classification considered rationale 1. Preparation, in the form of a powder, consisting of 92 % sugar, 6 % 2106.90 GRIs 1 and 6 black currant powder, anticaking agent, citric acid and black currant flavouring, put up for retail sale in 32-gram sachets, intended to be consumed as a beverage after mixing with hot water. 2. Vanutide cridificar (INN List 100). 3002.20 3. Certain INN products. Chapters 28, 29 (See “INN List 101” at the end of this publication.) and 30 4. Certain INN products. Chapters 13, 29 (See “INN List 102” at the end of this publication.) and 30 5. Certain INN products. Chapters 28, 29, (See “INN List 103” at the end of this publication.) 30, 35 and 39 6. Re-classification of INN products.
  • Gray Whales in the North Pacific: History, Biology, and Current Research

    Gray Whales in the North Pacific: History, Biology, and Current Research

    Gray Whales in the North Pacific: History, biology, and current research Aimée Lang Marine Mammal and Turtle Division Southwest Fisheries Science Center 13 October 2015 Photo courtesy of San Diego Natural History Museum Whalers W. Perryman Photo credit: Wayne Perryman, SWFSC Overview: • Taxonomic history • Physical description • Gray whale biology and life history • How we study gray whales and what we’ve learned! Taxonomic history: • First described based on subfossil remains from the coast of Sweden (Lilljeborg 1861) • “Eschrichtius” – named after a Danish zoologist (Dr. Daniel Eschricht) who was the first to suggest the remains might be from a new genus and family • “robustus” – Latin for strong Relationship to other baleen whales: • Fossil record is generally sparse but suggests higher diversity in the past • Today the gray whale is the only living species in its genus and family • Although traditionally considered morphologically distinct from the rorqual whales, molecular analyses indicate that gray whales are closely related to balaenopterid whales Sasaki et al. 2005, mitogenome analysis Physical characteristics: • Heart-shaped blow • Mottled gray and white coloration • Dorsal hump followed by series of 6 to 12 “knuckles” • Yellowish white baleen • Fewest baleen plates of any mysticete (130-180 plates on each side of mouth) • 2-5 throat grooves Size: • Adult body 11 to 15 m and weigh 45,000 kg • Females are larger than males • Calves 4.6 to 4.9 m at birth and weigh 700-900 kg Gray whale barnacles (Cryptolepas rhachianecti): • Considered
  • Sublingual Pythiosis in a Cat Jessica Sonia Fortin1, Michael John Calcutt2 and Dae Young Kim1*

    Sublingual Pythiosis in a Cat Jessica Sonia Fortin1, Michael John Calcutt2 and Dae Young Kim1*

    Fortin et al. Acta Vet Scand (2017) 59:63 DOI 10.1186/s13028-017-0330-z Acta Veterinaria Scandinavica CASE REPORT Open Access Sublingual pythiosis in a cat Jessica Sonia Fortin1, Michael John Calcutt2 and Dae Young Kim1* Abstract Background: Pythiosis is a potentially fatal but non-contagious disease afecting humans and animals living in tropi- cal and subtropical climates, but is also reasonably widespread in temperate climates, throughout the world. The most commonly reported afected animal species with pythiosis are equine and canine, with fewer cases in bovine and feline. Extracutaneous infections caused by Pythium insidiosum have been rarely described in the cat. Case presentation: Sublingual pythiosis was diagnosed in a 2-year-old, male, Domestic Shorthair cat. The cat had a multilobulated, sublingual mass present for 3 months. Histopathological examination revealed severe multifocal coalescing eosinophilic granulomatous infammation. Centers of the infammation contained hyphae that were 3–7 μm-wide, non-parallel, uncommonly septate and rarely branching. The fungal-like organism was identifed as P. insid- iosum by polymerase chain reaction and subsequent amplicon sequencing. Conclusions: Only a few feline pythiosis cases have been reported and, when encountered, it usually causes granu- lomatous diseases of the skin or gastrointestinal tract. This case presents an unusual manifestation of feline pythiosis, representing the frst involving the oral cavity in cats or dogs. Keywords: Eosinophilic granulomatous infammation, Feline, Hyphae, Pythium insidiosum, Sublingual mass Background trauma in Afghanistan [5]. Animals afected by the dis- Pythiosis is a potentially fatal but non-contagious disease ease are often younger and exposed to warm, freshwa- afecting humans and animals living in tropical and sub- ter habitats [1].